Altimmune, Inc. News
Cramer's Mad Money Recap: PepsiCo, JPMorgan Chase, Goldman Sachs
Jim Cramer says investors need to watch out for next week's economic data, COVID news and bank earnings. He's got your game plan.
Medicinova Jumps on Phase 2 Progress With Alcohol-Abuse Drug
Medicinova's clinical trials found that its ibudilast reduced the odds of heavy drinking over time by 45% relative to a placebo.
Nanox Higher on Application to FDA for Medical Imaging System
Nanox shares climbed after the medical-imaging-tech company applied to the FDA for clearance of a system that produces scans of human body parts.
Altimmune Higher After Phase 1 Progress With Obesity Drug
Altimmune jumped after it reported progress from its Phase 1 trial of ALT-801, a drug for obesity and liver disease.
Altimmune's Covid Vaccine Candidate Placed on Clinical Hold
Altimmune says it doesn't expect 'a significant impact on the overall clinical development timeline.'
Disney Fans Angry, Excited About New Guardians of the Galaxy Ride
The theme park company has opened Guardians of the Galaxy: Cosmic Rewind and not everyone is happy despite the ride getting wonderful reviews.
Aurora Cannabis Slashing Weed Capacity in Profitability Push
Aurora is slashing its production capacity as it builds a runway toward positive Ebitda a year from now.